StonvexLoading…
StonvexStonvexStonvexCore line items from DOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.05B | $8.09B | $5.99B | $3.92B |
Operating Income | $305.91M | $1.37B | $1.03B | $650.91M |
Net Income | $238.43M | $1.09B | $811.88M | $509.88M |
EPS (Diluted) | $1.75 | $7.94 | $5.88 | $3.69 |
Total Assets | $13.51B | $13.42B | $13.42B | $13.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.64B | $1.68B | $1.55B | $1.26B |
Free Cash Flow OCF − CapEx | $131.19M | $1.12B | $630.78M | $260.69M |
Shares Outstanding | 135.90M | 137.78M | 138.10M | 138.13M |